1.Department of Life Science Engineering, Faculty of New Sciences & Technologies,University of Tehran,Tehran,Iran;2.Medical Biomaterials Research Center,Tehran University of Medical Sciences,Tehran,Iran;3.Center of Excellence in Electrochemistry, Faculty of Chemistry,University of Tehran,Tehran,Iran;4.Biosensor Research Center, Endocrinology & Metabolism Molecular-Cellular Sciences Institute,Tehran University of Medical Sciences,Tehran,Iran
Abstract:
The authors report on a new approach for the determination of the breast cancer biomarker microRNA-155 (miRNA-155). It is based on the measurement of the fluorescence shift of oligonucleotide-templated copper nanoclusters (DNA-CuNC). A probe DNA was designed that acts as a template for the preparation of CuNC which, under 400 nm excitation, exhibit strong fluorescence enhancement at 490 nm and a 90 nm Stokes shift after binding to target miRNA-155 and formation of a DNA-RNA heteroduplex. Under the optimal conditions, the fluorescence of the DNA-CuNC increases with increasing concentration of miRNA-155 in the range from 50 pM to 10 nM, with a 11 pM detection limit. The assay has excellent selectivity over noncomplementary RNA. The method was applied to the determination of miRNA-155 in the presence of human plasma and saliva.
Graphical abstract Schematic of the detection strategy that relies on the fluorescence shift of DNA-CuNCs resulting from the specific binding of DNA-CuNCs with target miRNA-155. Fluorescence intensities are linearly proportional to the concentrations of target RNA from 50 pM to 10 nM.
